Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
BMC Psychiatry
Published in: BMC Psychiatry 1/2017

Open Access 01-12-2017 | Research article

Increasing the treatment motivation of patients with somatic symptom disorder: applying the URICA-S scale

Authors: Johannes Mander, Georg Schaller, Hinrich Bents, Ulrike Dinger, Stephan Zipfel, Florian Junne

Published in: BMC Psychiatry | Issue 1/2017

Login to get access

Abstract

Background

Therapeutic intervention programs for somatic symptom disorder (SSD) show only small-to-moderate effect sizes. These effects are partly explained by the motivational problems of SSD patients. Hence, fostering treatment motivation could increase treatment success. One central aspect in SSD patients might be damage to motivation because of symptomatic relapses. Consequently, the aim of the present study was to investigate associations between motivational relapse struggle and therapeutic outcome in SSD patients.

Methods

We assessed 84 inpatients diagnosed with SSD in the early, middle and late stages of their inpatient treatment. The maintenance subscale of the University of Rhode Island Change Assessment-Short (URICA-S) was applied as a measure to assess motivational relapse struggle. Additionally, patients completed measures of treatment outcome that focus on clinical symptoms, stress levels and interpersonal functioning.

Results

The results from multiple regression analyses indicate that higher URICA-S maintenance scores assessed in early stages of inpatient treatment were related to more negative treatment outcomes in SSD patients.

Conclusions

SSD patients with ambivalent treatment motivation may fail in their struggle against relapse over the course of therapy. The URICA-S maintenance score assessed at therapy admission facilitated early identification of SSD patients who are at greater risk of relapse. Future studies should incorporate randomized controlled trials to investigate whether this subgroup could benefit from motivational interventions that address relapse.
Appendix
Available only for authorised users
Literature
1.
American Psychological Association. Diagnostic and statistical Manual of mental disorders - DSM-5. 5th ed. Washington, D.C.: American Psychiatric Publishing; 2013.CrossRef
2.
Rief W, Rojas G. Stability of somatoform symptoms--implications for classification. Psychosom Med. 2007;69(9):864–9.CrossRefPubMed
3.
Jackson JL, Kroenke K. Prevalence, impact, and prognosis of multisomatoform disorder in primary care: a 5-year follow-up study. Psychosom Med. 2008;70(4):430–4.CrossRefPubMed
4.
de Waal MWM, Arnold IA, Eekhof JAH, van Hemert AM. Somatoform disorders in general practice: prevalence, functional impairment and comorbidity with anxiety and depressive disorders. Br J Psychiatry. 2004;184(6):470–6.CrossRefPubMed
5.
Gottschalk J-M, Bleichhardt G, Kleinstäuber M, Berking M, Rief W. Erweiterung der kognitiven verhaltenstherapie um emotionsregulationstraining bei patienten mit multiplen somatoformen symptomen: Ergebnisse einer kontrollierten pilotstudie. = extension of CBT by emotion regulation training in patients with multiple somatoform symptoms. Verhaltenstherapie. 2015;25(1):13–21.CrossRef
6.
Martin A, Rief W. Relevance of cognitive and behavioral factors in medically unexplained syndromes and somatoform disorders. Psychiatr Clin N Am. 2011;34(3):565–78.CrossRef
7.
Kleinstäuber M, Witthoft M, Hiller W. Efficacy of short-term psychotherapy for multiple medically unexplained physical symptoms: a meta-analysis. Clin Psychol Rev. 2011;31(1):146–60.CrossRefPubMed
8.
van Dessel N, den Boeft M, van der Wouden JC, Kleinstauber M, Leone SS, Terluin B, Numans ME, van der Horst HE, van Marwijk H. Non-pharmacological interventions for somatoform disorders and medically unexplained physical symptoms (MUPS) in adults. The Cochrane database of systematic reviews. 2014;11:Cd011142.
9.
Kleinstäuber M, Gottschalk J, Berking M, Rau J, Rief W. Enriching cognitive behavior therapy with emotion regulation training for patients with multiple medically unexplained symptoms (ENCERT): design and implementation of a multicenter, randomized, active-controlled trial. Contemporary clinical trials. 2016;47:54–63.CrossRefPubMed
10.
Heider J, Kock K, Sehlbrede M, Schroder A. Readiness to change as a moderator of therapy outcome in patients with somatoform disorders. Psychotherapy research: journal of the Society for Psychotherapy Research. 2017:1–12.
11.
Prochaska JO, Norcross JC. Systems of psychotherapy: a transtheoretical analysis 8edn. Belmont, CA US: Thomson Brooks/Cole Publishing Co; 2013.
12.
Prochaska JO, DiClemente CC. Transtheoretical therapy: toward a more integrative model of change. Psychotherapy: Theory, Research & Practice. 1982;19(3):276–88.CrossRef
13.
14.
Prochaska JO, DiClemente CC. Stages and processes of self-change of smoking: toward an integrative model of change. J Consult Clin Psychol. 1983;51(3):390–5.CrossRefPubMed
15.
Mander J, Wittorf A, Klingberg S, Teufel M, Zipfel S, Sammet I. The patient perspective on therapeutic change: the investigation of associations between stages of change and general mechanisms of change in psychotherapy research. J Psychother Integr. 2014;24(2):122–37.CrossRef
16.
McConnaughy EA, Prochaska JO, Velicer WF. Stages of change in psychotherapy: measurement and sample profiles. Psychotherapy: Theory, Research & Practice. 1983;20(3):368–75.CrossRef
17.
Maurischat C. Erfassung der 'Stages of Change' im Transtheoretischen Modell-eine Übersicht dimensionaler versus kategorialer Ansätze [assessment of the "stages of change" using the Transtheoretical model - an overview of dimensional versus categorical approaches]. Z Klin Psychol Psychiatr Psychother. 2002;50(4):343–67.
18.
Mander J, Wittorf A, Teufel M, Schlarb A, Hautzinger M, Zipfel S, Sammet I. Patients with depression, somatoform disorders, and eating disorders on the stages of change: validation of a short version of the URICA. Psychotherapy. 2012;49(4):519–27.CrossRefPubMed
19.
Junne F, Ziser K, Mander J, Martus P, Denzer C, Reinehr T, Wabitsch M, Wiegand S, Renner T, Giel KE, et al. Development and psychometric validation of the 'Parent perspective University of Rhode Island Change Assessment-Short' (PURICA-S) Questionnaire for the application in parents of children with overweight and obesity. BMJ Open. 2016;6(11):e012711.CrossRefPubMedPubMedCentral
20.
Carbonari JP, DiClemente CC. Using transtheoretical model profiles to differentiate levels of alcohol abstinence success. J Consult Clin Psychol. 2000;68(5):810–7.CrossRefPubMed
21.
Mander J, Teufel M, Keifenheim K, Zipfel S, Giel KE. Stages of change, treatment outcome and therapeutic alliance in adult inpatients with chronic anorexia nervosa. BMC Psychiatry. 2013;13:111.CrossRefPubMedPubMedCentral
22.
Giel KE, Leehr EJ, Becker S, Herzog W, Junne F, Schmidt U, Zipfel S. Relapse prevention via videoconference for anorexia nervosa - findings from the RESTART pilot study. Psychother Psychosom. 2015;84(6):381–3.CrossRefPubMed
23.
Kerns RD, Rosenberg R, Jamison RN, Caudill MA, Haythornthwaite J. Readiness to adopt a self-management approach to chronic pain: the pain stages of change Questionnaire (PSOCQ). Pain. 1997;72(1–2):227–34.CrossRefPubMed
24.
Maurischat C, Härter M, Bengel J. Der Freiburger Fragebogen - Stadien der Bewältigung chronischer Schmerzen (FF-STABS): Faktorenstruktur, psychometrische Eigenschaften und Konstruktvalidierung. [The Freiburg Questionnaire - Stages of Chronic Pain Management (FQ-STAPM): Factorial structure, psychometric properties and construct validation]. Diagnostica. 2002;48(4):190–9.CrossRef
25.
Maurischat C, Härter M, Kerns RD, Bengel J. Further support for the pain stages of change model: suggestions for improved measurement. Eur J Pain. 2006;10(1):41–9.CrossRefPubMed
26.
Derogatis LR, Fitzpatrick M: The SCL-90-R, the Brief Symptom Inventory (BSI), and the BSI-18. In: The use of psychological testing for treatment planning and outcomes assessment: Volume 3: Instruments for adults (3rd ed). edn. Edited by Maruish ME. Mahwah, NJ US: Lawrence Erlbaum Associates Publishers; 2004: 1–41.
27.
Levenstein S, Prantera C, Varvo V, Scribano ML, Berto E, Luzi C, Andreoli A. Development of the Perceived stress Questionnaire: a new tool for psychosomatic research. J Psychosom Res. 1993;37(1):19–32.CrossRefPubMed
28.
Horowitz LM, Rosenberg SE, Baer BA, Ureño G, Villaseñor VS. Inventory of interpersonal problems: psychometric properties and clinical applications. J Consult Clin Psychol. 1988;56(6):885–92.CrossRefPubMed
29.
Wittchen HU, Wunderlich U, Gruschwitz S, Zaudig M. Strukturiertes Klinisches Interview für DSM-IV (SKID I) [the structured clinical Interview for DSM-IV (SCID I)]. Göttingen, Germany: Hogrefe; 1997.
30.
American Psychiatric A. Falkai P, Wittchen H-U, Döpfner M, Gaebel W, Maier W, Rief W, Saß: Diagnostisches und Statistisches Manual Psychischer Störungen DSM-5 [Diagnostic and Statistical Manual of Mental Disorders DSM-5]. Göttingen: Hogrefe; 2015.
31.
Franke GH. Die Symptom-Checkliste von L. R. Derogatis (1977) - Deutsche Version [Symptom Check List 90 Items Revised (Derogatis, L.R., 1977) - German version]. Beltz Test GmbH: Göttingen; 2002.
32.
Fliege H, Rose M, Arck P, Levenstein S, Klapp BF. Validierung des 'Perceived Stress Questionnaire' (PSQ) an einer deutschen Stichprobe. Diagnostica. 2001;47(3):142–52.CrossRef
33.
Brähler E, Horowitz LM, Kordy H, Schumacher J, Strauß B. Zur Validierung des Inventars zur Erfassung Interpersonaler Probleme (IIP)—Ergebnisse einer Repräsentativbefragung in Ost- und Westdeutschland [validation of the Inventory of interpersonal problems - results of a Represantative investigation in east- and West-Germany]. Psychother Psychosom Med Psychol. 1999;49(11):422–31.PubMed
34.
Horowitz LM. The study of interpersonal problems: a Leary legacy. J Pers Assess. 1996;66(2):283–300.CrossRefPubMed
35.
Miller W, Rollnick S. Motivational interviewing. Preparing people to change addictive behaviour. New York: Guildford Press; 1991.
Metadata
Title
Increasing the treatment motivation of patients with somatic symptom disorder: applying the URICA-S scale
Authors
Johannes Mander
Georg Schaller
Hinrich Bents
Ulrike Dinger
Stephan Zipfel
Florian Junne
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Psychiatry / Issue 1/2017
Electronic ISSN: 1471-244X
DOI
https://doi.org/10.1186/s12888-017-1400-5

Other articles of this Issue 1/2017

BMC Psychiatry 1/2017 Go to the issue

Research article

Self-injury and externalizing pathology: a systematic literature review

Research article

Patients on outpatient commitment orders in Northern Norway

Study protocol

Design of the Lifestyle Interventions for severe mentally ill Outpatients in the Netherlands (LION) trial; a cluster randomised controlled study of a multidimensional web tool intervention to improve cardiometabolic health in patients with severe mental illness

Research article

Validating the psychiatric nurses methods of coping questionnaire: Arabic version

Research article

Mental health literacy among pediatric hospital staff in the United Arab Emirates

Research article

What is the significance of onconeural antibodies for psychiatric symptomatology? A systematic review